Urgent Parliamentary Intervention Sought to Redirect CERN Funding Towards Life-Saving Innovations

The Crosetto Foundation for the Reduction of Cancer Deaths has issued a compelling call to Members of the European Parliament (MEPs) to intervene in the allocation of CERN's funding. The foundation argues that for over 30 years, CERN has misallocated public funds by not adopting Dario Crosetto's 3D-Flow technology, a move that could have saved billions and advanced life-saving medical technologies.

Crosetto's 3D-Flow architecture, recognized as a breakthrough in 1993 by a scientific panel at FERMILAB, offers unparalleled efficiency in processing ultra-high-data streams. This technology not only has the potential to revolutionize particle physics research at CERN but also underpins the 3D-Complete Body Screening (3D-CBS), an advanced PET/CT technology for early disease detection, including cancer. Despite its proven superiority and cost-effectiveness, CERN has continued to invest in Field Programmable Gate Array (FPGA)-based architectures, which have repeatedly failed to meet performance requirements.

The implications of this misallocation are profound. Beyond the wasted taxpayer money, the delay in adopting 3D-Flow technology has postponed the realization of its benefits in physics, medicine, and defense. The Crosetto Foundation's call for a parliamentary question aims to redirect funding towards technologies that not only meet CERN's experimental needs but also have the potential to save lives through early cancer detection.

The foundation's appeal underscores a broader issue of accountability and transparency in the use of public funds for scientific research. By advocating for a public scientific comparison between CERN's current FPGA-based systems and Crosetto's 3D-Flow technology, the foundation seeks to ensure that future funding decisions are based on merit and efficiency, rather than inertia.

This situation serves as a critical reminder of the importance of oversight in public funding of scientific research. The potential benefits of redirecting funds towards more efficient and life-saving technologies like 3D-Flow cannot be overstated. It is a call to action for MEPs and the scientific community to prioritize innovation, efficiency, and the public good in the allocation of research funding.